GH Research Stock Quote GHRS - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
GH Research PLC (GHRS) Quote

GH Research PLC (GHRS)

9.27

-0.35

(-3.64%)

Closed November 23 4:00PM

Delayed by 15 minutes

9.245

-0.025

(-0.27%)

After Hours: 7:59PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

9.27

Bid

9.03

Ask

10.50

Volume

61,801

9.05 Day's Range 9.945

5.05 52 Week Range 14.99

Market Cap

Previous Close

9.62

Open

9.57

Last Trade

Last Trade Time

Financial Volume

$ 583,309

VWAP

9.4385

Average Volume (3m)

59,025

Shares Outstanding

52,028,145

Dividend Yield

-

PE Ratio

-13.51

Earnings Per Share (EPS)

-0.68

Revenue

-

Net Profit

-35.59M

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ghres.com

Headquarters

Dublin, Irl

Founded

-

GH Research PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GHRS. The last closing price for GH Research was $9.62. Over the last year, GH Research shares have traded in a share price range of $ 5.05 to $ 14.99.

GH Research currently has 52,028,145 shares outstanding. The market capitalization of GH Research is $500.51 million. GH Research has a price to earnings ratio (PE ratio) of -13.51.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and expected completion of 6-month open-label...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.43	-4.43298969072	9.7	11.09	8.56	108709	9.63903986	CS
4	1.76	23.4354194407	7.51	11.09	7.394	72471	8.91968809	CS
12	-1.67	-15.2650822669	10.94	11.09	6	59025	8.01734571	CS
26	-3.1	-25.0606305578	12.37	14.99	6	50169	9.82767387	CS
52	3.26	54.2429284526	6.01	14.99	5.05	77885	8.91861462	CS
156	-16.98	-64.6857142857	26.25	27.78	5.05	79070	12.09984623	CS
260	-12.73	-57.8636363636	22	30.43	5.05	81633	13.47279337	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	$ 8.26 (89.02%)	2.03M
XCURExicure Inc	$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	$ 8.24 (18.05%)	107.91M

Whalatane

Whalatane 3 minutes ago

https://higherlogicdownload.s3.amazonaws.com/NRAA/8eb5e347-a0f4-4216-aac1-f22e0d697983/UploadedImages/Content/2024/RHA_Advocates_to_Protect_Access_to_Phosphate-Lowering_Therapies_11_21_24.pdf

Kiwi

DarkPool

DarkPool 3 minutes ago

Absolutely. It's on the stellar network also

Welcome2Pinkyland

Welcome2Pinkyland 3 minutes ago

Good one stock_scammer

chemist72

chemist72 4 minutes ago

"stock prices are heavily influenced by perceptions and emotions"
very true. especially on the OTC. For many OTC companies, fundamentals like revenue and earnings are negligible and so share prices are almost always speculative in that sense.

At this point, I consider MVNT to b

sealskin123

sealskin123 4 minutes ago

The better question would be Did you buy this garbage???

exwannabe

exwannabe 4 minutes ago

Yes but the experiments are already done… and importantly, done using the Flaskworks’ Edens.
They did NOT say that.

We know as fact that the Flaskworks team has experience analyzing characteristics of DCs. So they would be the logical team to do this. As the process would be n

jjjjjjjj

jjjjjjjj 4 minutes ago

wow✅Green is Good✅Set HIGH Sell Orders✅SET BUY HIGH with LAST MINUTE✅Great Great Advice✅

I REST MY CASE. I REST MY CASE.
$0.0005 , $0.0004, $0.0003, $0.0002, $0.0001,…, $0.000001 coming?
ARE WE THERE YET?
Please 1vman, do something.
MJNA is a good company.

WeTheMarket

WeTheMarket 5 minutes ago

Steve, a drone video was posted yesterday by Plug Power partner HevenDrones (below is PR on partnership).

Plug Power Enters Alliance with HevenDrones to Commercialize Hydrogen Drones
October 19, 2021
https://finance.yahoo.com/news/plugpower-enters-alliance-hevendrones-co

bigstocksnbonds

bigstocksnbonds 6 minutes ago

My you've been BUSY BUSY CONGRATS!!!

Investor082

Investor082 6 minutes ago

BS, as usual! You added “massive”.

Besides, they are broke and big pharma is not going to inject upfront cash. But continue to create false hope as you have been doing for the last decade here.

dinogreeves

dinogreeves 7 minutes ago

Look at this beautiful chart and set up. SMCI has the same setup pattern as CVN*A. If for whatever reason your gold fish attention span is lacking to see what is happening, then sell and move on, no one can help you but yourself to reap the rewards. This kind of setup are extremely rare.

zab

zab 7 minutes ago

Los Angeles county has more people than each of 27 states in America.

georgebailey

georgebailey 8 minutes ago

What I’ve been focused on is how nwbo is leveraging diagnostic tools to run “experiments” that are designed to pinpoint combinations that are highly likely to succeed in trials and commercialize.We are talking about saving years and billions in failed attempts and therefore created a very real new p

TKS PARTY

TKS PARTY 8 minutes ago

Dangriff, The land all 72 acres is beyond valuable and will play out big and maybe sooner than we think. If Lawrence and Mills had a clue a nice Thanksgiving update would go a long way ! The Land if you build it they will come !!! Hang in there.

vinmantoo

vinmantoo 9 minutes ago

Experts, believe that there’s greater than an 80% probability that this company will not exist for even another two years.

Two years more to get the company into shape is a nice is a runway.

J_Dean

J_Dean 9 minutes ago

Anyone like FLR as well? With Xrp going up, FLr should follow?

learningcurve2020

learningcurve2020 10 minutes ago

Impressive.

https://www.msn.com/en-us/health/other/groundbreaking-clinical-trial-cures-cancer-

yp_1

yp_1 10 minutes ago

Gary, you are even more pessimistic than I am.

ChannelTrader

ChannelTrader 10 minutes ago

US Navy Submarine SURFACES WITHIN Chinese Fleet: What Comes Next?

https://www.youtube.com/watch?v=hczlYOcDP_o

helpx

helpx 11 minutes ago

From mcol52 in stocktwits
"He also said that there is a plan as well as financing strategy in place to expand and that they are moving forward. He is "moving slow to avoid expensive mistakes" but feels that they will pick up momentum and have to increase manufacturing in Q1"

ChannelTrader

ChannelTrader 11 minutes ago

I wouldn't doubt it.

SC8

SC8 12 minutes ago

What false narratives? I'm just citing the facts per MK's own downdate released yesterday. Per that downdate:

There will be more meetings with FDA of unknown number or duration on various unresolved issues of an unstated nature before IDE submission.
No timetable for these m

1plus1

1plus1 13 minutes ago

copy cat , same old posts and repeats

HoldHigh

HoldHigh 13 minutes ago

Like I said before the failure of Amendment 3 in FL will result in more medical patients. Last week FL OMMU indicated there were over 2k new patients added over the last week. I expect these numbers to keep climbing. This is the only legal way to get MJ in FL.

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions